Propylhexedrine Abuse Prompts US FDA To Suggest OTC Nasal Inhaler Modifications, Smaller Size

Researchers Say Little Attention Given To Decongestant Ingredient’s Abuse Risk

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.